PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Modulation of Post-Traumatic Immune Response Using the IL-1 Receptor Antagonist Anakinra for Improved Visual Outcomes.

Mouse / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32056479 ↗2020Reported benefit

Modulation of Post-Traumatic Immune Response Using the IL-1 Receptor Antagonist Anakinra for Improved Visual Outcomes.

MouseTBIBlast / overpressureC57BL/6JMaleIntraperitonealStarted one week before injury and continued for three weeks after injury

Model: Blast-mediated traumatic brain injury, three 20 psi blast waves directed at the head with the body shielded, one hour between blasts

Blast exposure increased retinal proinflammatory cytokine expression and activated microglia and macroglia. Anakinra preserved retinal ganglion cell function and retinal ganglion cell layer thickness compared with saline, with a trend toward decreased optic nerve damage.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.